Cargando...
Safety and tolerability of new-generation anti-obesity medications: a narrative review
The prevalence of obesity and associated comorbidities is rising. Despite their weight-loss efficacy, new generation anti-obesity medications are only prescribed to a minority of adults with obesity, possibly, which in part may be due to safety concerns. This review presents detailed safety profiles...
Gardado en:
| Publicado en: | Postgrad Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6261426/ https://ncbi.nlm.nih.gov/pubmed/29388462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00325481.2018.1435129 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|